Cibc Private Wealth Group, LLC Haemonetics Corp Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 502 shares of HAE stock, worth $28,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
502
Previous 445
12.81%
Holding current value
$28,699
Previous $35,000
11.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
345Shares Held
52MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$341 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$296 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$253 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$242 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$146 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.93B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...